A Study to Evaluate Safety, Tolerability, and Efficacy of Lecanemab in Subjects With Early Alzheimer’s Disease
Condition(s):Alzheimer’s DiseaseLast Updated:May 3, 2023Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Alzheimer’s DiseaseLast Updated:May 3, 2023Active, not recruiting
Condition(s):Idiopathic Pulmonary FibrosisLast Updated:August 11, 2020Completed
Condition(s):Colorectal NeoplasmsLast Updated:September 18, 2017Terminated
Condition(s):Type 2 Diabetes Mellitus; Cardiovascular DiseaseLast Updated:May 29, 2015Terminated
Condition(s):Cavernous Angioma, Familial; Cerebral Cavernous Malformations; Cerebral Cavernous HemangiomaLast Updated:December 26, 2023Recruiting
Condition(s):Osteoarthritis; Osteoarthritis, Knee; OsteonecrosisLast Updated:April 23, 2021Terminated
Condition(s):PresbyopiaLast Updated:June 19, 2018Completed
Condition(s):Safety of the ProMRI Pacemaker System Under Specific MRI ConditionsLast Updated:February 9, 2017Completed
Condition(s):Postherpetic NeuralgiaLast Updated:December 12, 2013Completed
Condition(s):Leukemia, Myeloid, AcuteLast Updated:January 19, 2024Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.